ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes by Vieira de Sá, R, Sudria-Lopez, E, Cañizares Luna, M, Harschnitz, O, van den Heuvel, DMA, Kling, S, Vonk, D, Westeneng, H, Karst, H, Bloemenkamp, L, Varderidou-Minasian, S, Schlegel, DK, Mars, M, Broekhoven, MH, van Kronenburg, NCH, Adolfs, Y, Vangoor, VR, de Jongh, R, Ljubikj, T, Peeters, L, Seeler, S, Mocholi, E, Basak, O, Gordon, D, Talbot, K